首頁 > 市場調查報告書 > 醫療設備

e保健體外診斷藥物開發人工智能人工智能藥物研發診斷用人工智能

市場調查報告書

商品編碼

2059024

醫療人工智慧代理市場預測至2034年—按代理類型、技術、部署模式、組件、應用、最終用戶和地區分類的全球分析

Healthcare AI Agents Market Forecasts to 2034 - Global Analysis By Agent Type, Technology, Deployment Mode, Component, Application, End User and By Geography

出版日期: 2026年06月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球醫療 AI 代理市場預計將在 2026 年達到 31 億美元，到 2034 年達到 187 億美元，在預測期內以 25.0% 的複合年成長率成長。

醫療人工智慧代理是一種自主或半自主的人工智慧軟體系統，能夠感知複雜的醫療資料環境，跨多個資訊來源進行推理，並在極少人工干預的情況下執行半自動階段的臨床或管理任務。與傳統的決策支援工具不同，醫療人工智慧代理能夠主動採取行動、跨系統協調並適應動態的臨床情況，因此擴大應用於臨床記錄、診斷流程協調、護理計劃管理、患者推廣自動化以及醫療運營最佳化等領域。

醫療工作者嚴重短缺，迫切需要透過人工智慧來加強醫療服務。

全球醫療系統正面臨醫生、護士及相關專業嚴重短缺的困境，預計未來十年，由於專業老化、職業倦怠以及人口老化導致病患需求加速成長，這種情況將進一步惡化。人工智慧代理能夠從不堪重負的臨床醫生手中接手耗時的認知任務，進而提升現有醫療團隊的病患管理效率。隨著醫療服務能力因人員短缺而受到限制，投資人工智慧代理已成為尋求永續營運模式的醫療系統經營團隊的策略重點。

臨床管治中關於自主人工智慧代理在臨床過程中的行為的不確定性和問責框架

引入能夠自主執行臨床操作的人工智慧代理，引發了關於臨床課責、責任歸屬和管治等方面的許多深刻且尚未解決的問題。在大多數司法管轄區，對於人工智慧代理自主發起臨床溝通、修改護理計劃或下達診斷測試指令所導致的不利事件的責任歸屬，人工智慧開發人員、醫療系統採用者和主管臨床醫生之間仍存在法律上的模糊地帶。醫療機構採取謹慎的態度，施加了廣泛的人工監管要求。這極大地限制了人工智慧代理的運作自主性，從而削弱了其部署所帶來的效率提升。建立一個更清晰的法規結構，明確臨床人工智慧代理的適當範圍、監管要求和責任結構，是加速其應用普及的先決條件。

多智慧體人工智慧編配實現端到端臨床路徑自動化

多智慧體人工智慧架構的出現，使得不同臨床領域的專業人工智慧代理能夠在協調的工作流程中協同工作，從而實現了複雜診療路徑的端到端自動化，而這些路徑此前需要持續的人工協調。例如，對於新發現異常檢測結果的患者，診斷人工智慧代理可以協調影像檢查，通訊代理可以通知醫療團隊，調度代理可以安排後續追蹤——所有這些都可以在預定義的臨床方案範圍內自主運作。這種編配能力有望顯著減少診療協調中的延誤、漏診以及行政負擔。

人工智慧代理決策帶來的演算法偏見和醫療服務不平等風險

基於歷史臨床資料訓練的醫療人工智慧代理程序，可能會吸收並延續訓練資料集中存在的系統性偏見，包括與種族、性別、社會經濟地位和地理位置相關的差異。如果人工智慧代理程式透過診斷閾值的差異、帶有偏見的資源分配建議或與缺乏文化敏感性的患者溝通等方式，複製或放大醫療服務不平等的模式，那麼它們不僅無法糾正現有的醫療保健不平等，反而會加劇這些不平等。隨著人工智慧代理程式擴大影響到群體層面的關鍵臨床決策，演算法偏見對公平性的影響將遠比針對單一患者的診斷人工智慧應用更為顯著。

新冠疫情的影響：

新冠疫情為醫療人工智慧代理商提供了一個早期驗證概念的機會，因為醫療系統迫切需要可擴展的自動化系統來處理前所未有的大規模疫苗接種預約管理、患者分診溝通和接觸者追蹤工作流程。處理數百萬次疫苗接種預約請求的人工智慧自主通訊代理，在真正的危機中展現了基於代理的醫療自動化系統的實用能力和運作可靠性。疫情也暴露了醫療協調方面的不足，凸顯了人工智慧代理在人員短缺和患者數量激增的情況下改善醫療服務連續性的潛力。

在預測期內，臨床文檔代理領域預計將佔據最大的市場佔有率。

預計在預測期內，臨床文檔代理領域將佔據最大的市場佔有率。這反映了文件要求給所有醫療機構的臨床醫生帶來的巨大行政負擔。醫師花費在文件工作上的時間遠遠超過直接患者照護的時間，因此，能夠根據日常對話和結構化資料輸入產生準確的臨床記錄、出院小結和轉診信的自主代理具有極高的應用價值。對話式人工智慧文件平台的商業化正在迅速發展，大量證據表明，這些平台能夠節省醫生的時間並提高他們的滿意度。

在預測期內，「自主診斷支援代理」細分市場預計將呈現最高的複合年成長率。

在預測期內，「自主診斷輔助系統」細分市場預計將呈現最高的成長率，這主要得益於多模態人工智慧技術的快速發展，該技術能夠同時分析影像、實驗室、基因組和臨床說明數據，從而產生全面的診斷資訊。人工智慧在放射學、病理學和皮膚病學篩檢中的卓越診斷性能已得到證實，為將自主輔助系統整合到診斷流程中提供了強力的證據。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這得歸功於美國先進的人工智慧研究生態系統、在醫療技術領域的高額投資，以及許多世界領先的人工智慧平台公司積極推動醫療應用領域的產品開發。美國醫療保健系統複雜的計費和合規環境，使得醫生文件記錄工作日益繁重，這為人工智慧文件代理的普及應用創造了尤為有利的商業環境。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要得益於該地區作為人工智慧研發中心的重要地位、政府對醫療人工智慧基礎設施的大量投資，以及大規模的患者群體為臨床人工智慧模型開發提供了豐富的訓練資料集。中國的國家人工智慧策略優先考慮醫療應用，因此公共和私人部門對臨床人工智慧平台的開發和部署進行了大量投資。

主要公司：

醫療保健 AI 代理市場的主要參與者包括微軟公司、Google有限責任公司、亞馬遜網路服務 (AWS)、Oracle公司、英偉達公司、Salesforce.com、Epic Systems 公司、銷售團隊 Communications、Innovacker、Abridge AI、Quentus、Aidoc Medical、Tempus AI、Path AI 和 CureEye Technologies。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第12章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第13章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第14章：公司簡介

Microsoft Corporation
Google LLC
Amazon Web Services, Inc.
Oracle Corporation
NVIDIA Corporation
Salesforce, Inc.
Epic Systems Corporation
Nuance Communications, Inc.
Innovaccer Inc.
Abridge AI, Inc.
Qventus, Inc.
Aidoc Medical Ltd.
Tempus AI, Inc.
PathAI, Inc.
Qure.ai Technologies Pvt. Ltd.

簡介目錄圖表

Product Code: SMRC36609

According to Stratistics MRC, the Global Healthcare AI Agents Market is accounted for $3.1 billion in 2026 and is expected to reach $18.7 billion by 2034, growing at a CAGR of 25.0% during the forecast period. Healthcare AI Agents are autonomous or semi-autonomous artificial intelligence software systems capable of perceiving complex healthcare data environments, reasoning across multiple information sources, and executing multi-step clinical or administrative tasks with minimal human supervision. Distinguishing themselves from conventional decision support tools by their ability to initiate actions, coordinate across systems, and adapt to dynamic clinical contexts, healthcare AI agents are being deployed in clinical documentation, diagnostic pathway orchestration, care plan management, patient outreach automation, and healthcare operations optimization.

Market Dynamics:

Driver:

Severe clinical workforce shortages creating urgent demand for AI-powered care delivery augmentation

Healthcare systems worldwide face critical shortages of physicians, nurses, and allied health professionals that are projected to intensify significantly over the coming decade, driven by aging professional demographics, burnout-related attrition, and accelerating patient demand from aging populations. By absorbing time-consuming cognitive tasks from overburdened clinicians, AI agents extend the effective patient management capacity of existing healthcare teams. The urgency of workforce-driven care capacity constraints is making AI agent investment a strategic priority for health system executives seeking sustainable operating models.

Restraint:

Clinical governance uncertainty and liability frameworks for autonomous AI agent actions in care pathways

The deployment of AI agents capable of autonomous clinical action raises profound and as-yet inadequately resolved questions of clinical accountability, liability apportionment, and governance oversight. When an AI agent autonomously initiates a clinical communication, modifies a care plan element, or triggers a diagnostic order, the attribution of responsibility for any resulting adverse outcome among the AI developer, health system deployer, and supervising clinician remains legally ambiguous in most jurisdictions. Healthcare organizations are proceeding cautiously, implementing extensive human oversight requirements that substantially limit the operational autonomy and therefore the efficiency benefits of AI agent deployments. Clearer regulatory frameworks defining the appropriate scope, oversight requirements, and liability structures for clinical AI agents are prerequisites for accelerated adoption.

Opportunity:

Multi-agent AI orchestration enabling end-to-end clinical pathway automation

The emergence of multi-agent AI architectures where specialized AI agents collaborate across different clinical domains in coordinated workflows is creating the potential for end-to-end automation of complex care pathways previously requiring continuous human orchestration. A patient with a newly detected abnormal laboratory result could trigger a diagnostic AI agent to coordinate imaging, a communication agent to notify the care team, and a scheduling agent to arrange follow-up-all operating autonomously within predefined clinical protocols. This orchestration capability promises dramatic reductions in care coordination delays, missed follow-up rates, and administrative burden.

Threat:

Risk of algorithmic bias and inequitable care delivery through AI agent decision-making

Healthcare AI agents trained on historical clinical data are susceptible to encoding and perpetuating the systemic biases present in training datasets, including disparities related to race, gender, socioeconomic status, and geographic location. If AI agents replicate or amplify inequitable care patterns through differential diagnostic thresholds, biased resource allocation recommendations, or culturally insensitive patient communications they risk exacerbating rather than ameliorating existing healthcare disparities. As AI agents increasingly influence high-stakes clinical decisions at population scale, the equity implications of algorithmic bias become significantly more consequential than in single-patient diagnostic AI applications.

Covid-19 Impact:

COVID-19 created early demonstration opportunities for healthcare AI agents as health systems urgently needed scalable automation to manage vaccine scheduling, patient triage communications, and contract tracing workflows at unprecedented population scale. AI-powered autonomous communication agents handling millions of vaccination appointment interactions demonstrated the practical capability and operational reliability of agent-based healthcare automation during a genuine crisis. The pandemic's exposure of care coordination fragilities also highlighted the potential of AI agents to improve care continuity during staff shortages and surges.

The Clinical Documentation Agents segment is expected to be the largest during the forecast period

The Clinical Documentation Agents segment is expected to account for the largest market share during the forecast period, reflecting the enormous administrative burden that documentation requirements impose on clinicians across all healthcare settings. Physicians spend a disproportionate share of their working time on documentation tasks rather than direct patient care, creating a highly valued use case for autonomous agents capable of generating accurate clinical notes, discharge summaries, and referral letters from ambient conversation or structured data inputs. The commercial maturity of ambient AI documentation platforms has generated strong evidence of physician time savings and satisfaction improvements, driving rapid adoption.

The Autonomous Diagnostic Support Agents segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Autonomous Diagnostic Support Agents segment is predicted to witness the highest growth rate, propelled by rapidly advancing multi-modal AI capabilities that enable simultaneous analysis of imaging, laboratory, genomic, and clinical narrative data to generate comprehensive diagnostic insights. The demonstrated superiority of AI diagnostic performance in radiology, pathology, and dermatology screening is creating compelling evidence for autonomous agent integration in diagnostic pathways.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, anchored by the United States' advanced AI research ecosystem, high healthcare technology investment capacity, and the presence of the world's leading AI platform companies driving aggressive product development in healthcare applications. The acute physician documentation burden within the US healthcare system's complex billing and compliance environment has created a particularly fertile commercial environment for AI documentation agent adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by the region's position as a leading center of AI research and development, substantial government investment in healthcare AI infrastructure, and large patient populations creating rich training datasets for clinical AI model development. China's national AI strategy prioritizes healthcare applications, with significant public and private investment in clinical AI platform development and deployment.

Key Players:

Some of the key players in the Healthcare AI Agents Market include Microsoft Corporation, Google LLC, Amazon Web Services, Inc., Oracle Corporation, NVIDIA Corporation, Salesforce, Inc., Epic Systems Corporation, Nuance Communications, Inc., Innovaccer Inc., Abridge AI, Inc., Qventus, Inc., Aidoc Medical Ltd., Tempus AI, Inc., PathAI, Inc., and Qure.ai Technologies Pvt. Ltd.

Key Developments:

In February 2026, Microsoft Corporation announced the general availability of Dragon Ambient eXperience (DAX) Copilot on the Azure OpenAI platform with enhanced multi-specialty clinical documentation templates, enabling healthcare organizations to deploy AI-powered autonomous clinical note generation across inpatient, ambulatory, and virtual care settings with improved accuracy and compliance with specialty-specific documentation standards.

In January 2026, NVIDIA Corporation launched its Healthcare AI Agent Blueprint on the NVIDIA NIM platform, providing healthcare technology developers with optimized inference infrastructure and pre-built agent orchestration frameworks designed to accelerate the development and clinical deployment of multi-agent AI systems capable of coordinating complex diagnostic and care management workflows at enterprise scale.

Agent Types Covered:

Conversational AI Agents
Autonomous AI Agents
Multi-Agent Systems
Workflow Automation Agents
Clinical Decision Support Agents
Virtual Health Assistants
AI Voice Agents

Technologies Covered:

Machine Learning
Natural Language Processing (NLP)
Generative AI
Large Language Models (LLMs)
Computer Vision
Speech Recognition & Voice AI
Predictive Analytics

Deployment Modes Covered:

Cloud-Based
On-Premise
Hybrid Deployment

Components Covered:

Software Platforms
AI Agent Frameworks
Services

Applications Covered:

Clinical Documentation
Patient Engagement & Communication
Medical Diagnosis Assistance
Patient Triage & Symptom Checking
Remote Patient Monitoring
Revenue Cycle Management
Claims & Billing Automation
Appointment Scheduling
Drug Discovery & Research

End Users Covered:

Hospitals & Health Systems
Clinics & Physician Offices
Healthcare Payers
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Home Healthcare Providers
Patients & Consumers
Research Institutions
Other End Users

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare AI Agents Market, By Agent Type

5.1 Conversational AI Agents
5.2 Autonomous AI Agents
5.3 Multi-Agent Systems
5.4 Workflow Automation Agents
5.5 Clinical Decision Support Agents
5.6 Virtual Health Assistants
5.7 AI Voice Agents

6 Global Healthcare AI Agents Market, By Technology

6.1 Machine Learning
- 6.1.1 Supervised Learning
- 6.1.2 Unsupervised Learning
- 6.1.3 Reinforcement Learning
- 6.1.4 Deep Learning
6.2 Natural Language Processing (NLP)
6.3 Generative AI
6.4 Large Language Models (LLMs)
6.5 Computer Vision
6.6 Speech Recognition & Voice AI
6.7 Predictive Analytics

7 Global Healthcare AI Agents Market, By Deployment Mode

7.1 Cloud-Based
7.2 On-Premise
7.3 Hybrid Deployment

8 Global Healthcare AI Agents Market, By Component

8.1 Software Platforms
8.2 AI Agent Frameworks
8.3 Services
- 8.3.1 Consulting
- 8.3.2 Integration & Deployment
- 8.3.3 Support & Maintenance

9 Global Healthcare AI Agents Market, By Application

9.1 Clinical Documentation
9.2 Patient Engagement & Communication
9.3 Medical Diagnosis Assistance
9.4 Patient Triage & Symptom Checking
9.5 Remote Patient Monitoring
9.6 Revenue Cycle Management
9.7 Claims & Billing Automation
9.8 Appointment Scheduling
9.9 Drug Discovery & Research

10 Global Healthcare AI Agents Market, By End User

10.1 Hospitals & Health Systems
10.2 Clinics & Physician Offices
10.3 Healthcare Payers
10.4 Pharmaceutical & Biotechnology Companies
10.5 Diagnostic Laboratories
10.6 Home Healthcare Providers
10.7 Patients & Consumers
10.8 Research Institutions
10.9 Other End Users

11 Global Healthcare AI Agents Market, By Geography

11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
11.2 Europe
- 11.2.1 United Kingdom
- 11.2.2 Germany
- 11.2.3 France
- 11.2.4 Italy
- 11.2.5 Spain
- 11.2.6 Netherlands
- 11.2.7 Belgium
- 11.2.8 Sweden
- 11.2.9 Switzerland
- 11.2.10 Poland
- 11.2.11 Rest of Europe
11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Australia
- 11.3.6 Indonesia
- 11.3.7 Thailand
- 11.3.8 Malaysia
- 11.3.9 Singapore
- 11.3.10 Vietnam
- 11.3.11 Rest of Asia Pacific
11.4 South America
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Colombia
- 11.4.4 Chile
- 11.4.5 Peru
- 11.4.6 Rest of South America
11.5 Rest of the World (RoW)
- 11.5.1 Middle East
  - 11.5.1.1 Saudi Arabia
  - 11.5.1.2 United Arab Emirates
  - 11.5.1.3 Qatar
  - 11.5.1.4 Israel
  - 11.5.1.5 Rest of Middle East
- 11.5.2 Africa
  - 11.5.2.1 South Africa
  - 11.5.2.2 Egypt
  - 11.5.2.3 Morocco
  - 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles

14.1 Microsoft Corporation
14.2 Google LLC
14.3 Amazon Web Services, Inc.
14.4 Oracle Corporation
14.5 NVIDIA Corporation
14.6 Salesforce, Inc.
14.7 Epic Systems Corporation
14.8 Nuance Communications, Inc.
14.9 Innovaccer Inc.
14.10 Abridge AI, Inc.
14.11 Qventus, Inc.
14.12 Aidoc Medical Ltd.
14.13 Tempus AI, Inc.
14.14 PathAI, Inc.
14.15 Qure.ai Technologies Pvt. Ltd.

簡介目錄圖表

List of Tables

Table 1 Global Healthcare AI Agents Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Healthcare AI Agents Market Outlook, By Agent Type (2023-2034) ($MN)
Table 3 Global Healthcare AI Agents Market Outlook, By Conversational AI Agents (2023-2034) ($MN)
Table 4 Global Healthcare AI Agents Market Outlook, By Autonomous AI Agents (2023-2034) ($MN)
Table 5 Global Healthcare AI Agents Market Outlook, By Multi-Agent Systems (2023-2034) ($MN)
Table 6 Global Healthcare AI Agents Market Outlook, By Workflow Automation Agents (2023-2034) ($MN)
Table 7 Global Healthcare AI Agents Market Outlook, By Clinical Decision Support Agents (2023-2034) ($MN)
Table 8 Global Healthcare AI Agents Market Outlook, By Virtual Health Assistants (2023-2034) ($MN)
Table 9 Global Healthcare AI Agents Market Outlook, By AI Voice Agents (2023-2034) ($MN)
Table 10 Global Healthcare AI Agents Market Outlook, By Technology (2023-2034) ($MN)
Table 11 Global Healthcare AI Agents Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 12 Global Healthcare AI Agents Market Outlook, By Supervised Learning (2023-2034) ($MN)
Table 13 Global Healthcare AI Agents Market Outlook, By Unsupervised Learning (2023-2034) ($MN)
Table 14 Global Healthcare AI Agents Market Outlook, By Reinforcement Learning (2023-2034) ($MN)
Table 15 Global Healthcare AI Agents Market Outlook, By Deep Learning (2023-2034) ($MN)
Table 16 Global Healthcare AI Agents Market Outlook, By Natural Language Processing (NLP) (2023-2034) ($MN)
Table 17 Global Healthcare AI Agents Market Outlook, By Generative AI (2023-2034) ($MN)
Table 18 Global Healthcare AI Agents Market Outlook, By Large Language Models (LLMs) (2023-2034) ($MN)
Table 19 Global Healthcare AI Agents Market Outlook, By Computer Vision (2023-2034) ($MN)
Table 20 Global Healthcare AI Agents Market Outlook, By Speech Recognition & Voice AI (2023-2034) ($MN)
Table 21 Global Healthcare AI Agents Market Outlook, By Predictive Analytics (2023-2034) ($MN)
Table 22 Global Healthcare AI Agents Market Outlook, By Deployment Mode (2023-2034) ($MN)
Table 23 Global Healthcare AI Agents Market Outlook, By Cloud-Based (2023-2034) ($MN)
Table 24 Global Healthcare AI Agents Market Outlook, By On-Premise (2023-2034) ($MN)
Table 25 Global Healthcare AI Agents Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
Table 26 Global Healthcare AI Agents Market Outlook, By Component (2023-2034) ($MN)
Table 27 Global Healthcare AI Agents Market Outlook, By Software Platforms (2023-2034) ($MN)
Table 28 Global Healthcare AI Agents Market Outlook, By AI Agent Frameworks (2023-2034) ($MN)
Table 29 Global Healthcare AI Agents Market Outlook, By Services (2023-2034) ($MN)
Table 30 Global Healthcare AI Agents Market Outlook, By Consulting (2023-2034) ($MN)
Table 31 Global Healthcare AI Agents Market Outlook, By Integration & Deployment (2023-2034) ($MN)
Table 32 Global Healthcare AI Agents Market Outlook, By Support & Maintenance (2023-2034) ($MN)
Table 33 Global Healthcare AI Agents Market Outlook, By Application (2023-2034) ($MN)
Table 34 Global Healthcare AI Agents Market Outlook, By Clinical Documentation (2023-2034) ($MN)
Table 35 Global Healthcare AI Agents Market Outlook, By Patient Engagement & Communication (2023-2034) ($MN)
Table 36 Global Healthcare AI Agents Market Outlook, By Medical Diagnosis Assistance (2023-2034) ($MN)
Table 37 Global Healthcare AI Agents Market Outlook, By Patient Triage & Symptom Checking (2023-2034) ($MN)
Table 38 Global Healthcare AI Agents Market Outlook, By Remote Patient Monitoring (2023-2034) ($MN)
Table 39 Global Healthcare AI Agents Market Outlook, By Revenue Cycle Management (2023-2034) ($MN)
Table 40 Global Healthcare AI Agents Market Outlook, By Claims & Billing Automation (2023-2034) ($MN)
Table 41 Global Healthcare AI Agents Market Outlook, By Appointment Scheduling (2023-2034) ($MN)
Table 42 Global Healthcare AI Agents Market Outlook, By Drug Discovery & Research (2023-2034) ($MN)
Table 43 Global Healthcare AI Agents Market Outlook, By End User (2023-2034) ($MN)
Table 44 Global Healthcare AI Agents Market Outlook, By Hospitals & Health Systems (2023-2034) ($MN)
Table 45 Global Healthcare AI Agents Market Outlook, By Clinics & Physician Offices (2023-2034) ($MN)
Table 46 Global Healthcare AI Agents Market Outlook, By Healthcare Payers (2023-2034) ($MN)
Table 47 Global Healthcare AI Agents Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
Table 48 Global Healthcare AI Agents Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 49 Global Healthcare AI Agents Market Outlook, By Home Healthcare Providers (2023-2034) ($MN)
Table 50 Global Healthcare AI Agents Market Outlook, By Patients & Consumers (2023-2034) ($MN)
Table 51 Global Healthcare AI Agents Market Outlook, By Research Institutions (2023-2034) ($MN)
Table 52 Global Healthcare AI Agents Market Outlook, By Other End Users (2023-2034) ($MN)